BenzingaOctober 23, 2026 at 5:16 AM NY4 Days Ago
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $495
TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $465 to $495.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
